<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04562142</url>
  </required_header>
  <id_info>
    <org_study_id>CAD-det Validation</org_study_id>
    <nct_id>NCT04562142</nct_id>
  </id_info>
  <brief_title>A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study</brief_title>
  <official_title>Validation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease (The CAD-det Validation Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AusculSciences Canada Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AusculSciences Canada Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to collect acoustic, ECG, and clinical data from consenting&#xD;
      participants, so that AusculSciences can perform analysis on the sounds produced by the heart&#xD;
      and determine the accuracy of the CAD-det System for detecting CAD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective multi-center clinical trial. Using the CAD-det, acoustic and electrical&#xD;
      cardiac data will be collected from participants with intermediate pretest probability of CAD&#xD;
      who are referred to invasive coronary angiography (ICA). The CAD-det recording will be&#xD;
      administered prior to the scheduled ICA procedure. The data collected by CAD-det will be&#xD;
      processed using AusculSciences' Data Analysis Application (DAA) to produce a patient's&#xD;
      indication for CAD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>CAD-det</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CAD-det to validate:</measure>
    <time_frame>up to 1 Year</time_frame>
    <description>CAD-det to detect obstructive CAD as defined as QCA diameter stenosis greater than or equal to 50%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CAD-det to detect:</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Obstructive CAD as defined as QCA diameter stenosis greater than or equal to 50% stratified according to sex (men and women).&#xD;
Severity of CAD by QCA:&#xD;
0 - 25% diameter stenosis (Negative for obstructive CAD);&#xD;
25 - 50% diameter stenosis (Negative for obstructive CAD);&#xD;
50 - 69% diameter stenosis (Positive for obstructive CAD);&#xD;
70% or greater diameter stenosis (Positive for obstructive CAD); and&#xD;
Equivocal or non-diagnostic.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">395</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Atherosclerosis</condition>
  <condition>Coronary Occlusion</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CAD-det</intervention_name>
    <description>CAD-det test will be done on participants with suspected CAD clinically referred for ICA at a participating clinical investigation site.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Stable&#xD;
&#xD;
          2. &gt;/= 19 years old&#xD;
&#xD;
          3. Suspected obstructive CAD&#xD;
&#xD;
          4. Referred to ICA&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Documented CAD or coronary revascularization&#xD;
&#xD;
          2. Age &lt; 19 years old&#xD;
&#xD;
          3. Acute coronary syndromes&#xD;
&#xD;
          4. Congenital heart disease or heart transplantation&#xD;
&#xD;
          5. Dextrocardia&#xD;
&#xD;
          6. Uncontrolled irregular heart rhythm (atrial arrhythmia (fibrillation, flutter) or&#xD;
             frequent PACs or PVCs (&gt;10/minute))&#xD;
&#xD;
          7. Resting heart rate &gt; 110 bpm&#xD;
&#xD;
          8. Known hemodynamically-significant valvular heart disease, audible diastolic murmurs,&#xD;
             or hypertrophic or non-ischemic cardiomyopathy&#xD;
&#xD;
          9. Chest wall deformity or wounds in adhesive application areas&#xD;
&#xD;
         10. Pregnancy&#xD;
&#xD;
         11. Unwillingness or inability to provide informed consent or to comply with the study&#xD;
             protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ben Chow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institue Research Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa Spero, CRN, CCRP</last_name>
    <phone>613 763-0088</phone>
    <phone_ext>107</phone_ext>
    <email>melissa@ausculsciences.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John Phillips, BSc.</last_name>
    <phone>613 763-0088</phone>
    <email>john@ausculsciences.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Farrah Ahmed</last_name>
      <phone>613-696-7000</phone>
      <phone_ext>12697</phone_ext>
      <email>fahmed@ottawaheart.ca</email>
    </contact>
    <investigator>
      <last_name>Benjamin Chow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aun Yeong Chong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://ausculsciences.com</url>
    <description>Study Sponsor</description>
  </link>
  <reference>
    <citation>Makaryus AN, Makaryus JN, Figgatt A, Mulholland D, Kushner H, Semmlow JL, Mieres J, Taylor AJ. Utility of an advanced digital electronic stethoscope in the diagnosis of coronary artery disease compared with coronary computed tomographic angiography. Am J Cardiol. 2013 Mar 15;111(6):786-92. doi: 10.1016/j.amjcard.2012.11.039. Epub 2013 Jan 1.</citation>
    <PMID>23290309</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 18, 2020</study_first_submitted>
  <study_first_submitted_qc>September 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>September 18, 2020</last_update_submitted>
  <last_update_submitted_qc>September 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Occlusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

